There are 76 vaccine candidates for COVID-19, five of which are in clinical trials. It will take at least 18 months to determine if these vaccines are effective and safe enough to distribute en masse. Then, distributing them to millions of people will require an incredible feat of manufacturing.
But it can take five years to spin up a new manufacturing facility, says Paul Hudson, CEO at the pharmaceutical company Sanofi, which is working on a vaccine candidate, a potential treatment called Kevzara, and a home diagnostic test kit for COVID-19. To address this problem, the company is looking at how it can use existing manufacturing space to ramp up COVID-19 vaccines.
“We’re looking at stopping making some vaccines to make [room] for COVID-19,” he says. “To plan long-term you do need a warm facility that’s ready to go, that has got experts in it, that you can then start producing hundreds of millions of doses in months.”
Before the COVID-19…
Read More…
Source : fastcompany.com
Source link
